三博脑科：目前不涉及脑机接口产品相关业务

Core Viewpoint - The stock of Sanbo Brain Science (301293.SZ) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over two consecutive trading days on January 5 and 6, 2026 [1] Company Overview - Sanbo Brain Science is a medical service group specializing in neurology, primarily providing comprehensive medical services focused on advanced neurosurgery [1] - The company does not engage in the research, production, or sales of brain-computer interface products [1] Financial Impact - Revenue from neuromodulation technology constitutes a very small portion of the company's total revenue, having minimal impact on overall performance [1]